TrialBritish journal of cancer2023

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.

Penella J Woll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.